Which Six Companies Are in Michael King's Oncology Wheelhouse? Trefis I think chemotherapy will continue be used and Rituxan (rituximab; administered via infusion) will continue to be used, but now the new drugs will begin to be used in the relapse/refractory patient population. Researchers are also starting to see ... |
